West Pharmaceutical Services Inc
WST· NYSE
Released Apr 25, 2019, before the open
10-Q filed May 8, 2019, 38 days after period end · 0000105770-19-000020
| Metric | Q1 2019 | Q1 2018 | Q1 2017 | Q1 2016 |
|---|---|---|---|---|
| Revenue | $443.50M | $415.70M | $387.70M | $362.10M |
| Net Income | $55.40M | $43.60M | $60.90M | $22.10M |
| EPS Diluted |
West Pharmaceutical Services Inc · CIK 105770 · Engraved from SEC EDGAR
| $0.73 |
| $0.58 |
| $0.81 |
| $0.30 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.